Abstract: Methods, devices, and kits for measuring multiple analytes in a sample having a broad range of concentrations using optical diffraction are disclosed. Devices, methods, and kits useful for monitoring and diagnosing diabetes, cardiovascular disease, thyroid disease, hormone-related conditions, and sepsis are also described.

Abstract: The invention features methods and devices for the detection of biomarker complexes and their components and for the sequential detection of multiple epitopes of a biomarker. The invention also features methods for diagnosing disease and evaluating the efficacy of treatment of a subject with a disease.

Abstract: The invention features methods and devices for the detection of biomarker complexes and their components and for the sequential detection of multiple epitopes of a biomarker. The invention also features methods for diagnosing disease and evaluating the efficacy of treatment of a subject with a disease.

Abstract: The invention relates to method, devices, and kits for measuring multiple analytes in a sample having a broad range of concentrations using optical diffraction. Devices, methods, and kits useful for monitoring and diagnosing diabetes, cardiovascular disease, thyroid disease, hormone-related conditions, and sepsis are also described.

Abstract: The invention features methods and devices for the detection of antibodies. The invention also features methods for diagnosing disease and evaluating the efficacy of treatment of a subject with a disease.

Abstract: The invention features methods and devices for the detection of biomarker complexes and their components and for the sequential detection of multiple epitopes of a biomarker. The invention also features methods for diagnosing disease and evaluating the efficacy of treatment of a subject with a disease.

Abstract: This invention relates to the diagnosis and treatment of pre-Type 1 diabetes and Type-1 diabetes (T1D); particularly to the use of neuronal proteins as predictors of the disease; and most particularly to GFAP (glial fibrillary acidic protein); GAD65 (glutamic acid decarboxylase 65); NSE (neuron specific enolase; S100? and CNPase (2?, 3?-cyclic nucleotide 3?-phosphodiesterase) neuronal proteins useful for pre-Type 1 diabetes screening and/or staging.

Abstract: A method and an apparatus for impregnating one side of a porous board, such as gypsum boards, with a precise amount of compatible phase change material. A predetermined amount of the phase change material is applied at a predetermined uniform rate to the one surface of the board so that a predetermined amount of the phase change is impregnated. The rate of application is lower than the absorption rate of phase change material. Also, the temperature of the board must be above the melting point of the phase change material during the impregnation. The process and apparatus may be either a continuous, a semi-continuous or a batch operation, and the resulting product is intended as a building construction material.